News About: Pharm. Affairs
‘Acetaminophen’ would not be used as ‘anti-inflammatory agent’
In order to prevent mis/abuse of medicines, the government will entirely revise the current therapeutic category system.
As one of this year’s tasks, the Ministry of Food and Drug Safety(MFDS) announced to address th...
Credit card fees drop for small business owners like pharmacy
Credit card fees on stores with many customers making micropayments, like pharmacies and convenient stores, will drop this July.
Jong-Gu Choi, Director of the Financial Services Commission(FSC), had a meeting with pr...
FTC’s corrective order on company refusing to supply animal drugs got revoked at High Court
On the 22nd, the Korea Pharmaceutical Association(President Chan-Hwi Cho, KPA) said it was a shame that the Seoul High Court ruled to revoke the Fair Trade Commission’s(FTC) measure to impose a corrective order on Val...
Oxy Reckitt Benckiser appeals its efforts to pharmacists, hoping to improve its corporate image
‘Oxy Reckitt Benckiser’ which has taken public rage and ignorance with the ‘Oxy Humidifier Sterilizer’ crisis showed an unprecedented movement to improve its company image at the Seocho-gu Pharmaceutical Association g...
Government carries legal base to ‘obligate doctors to issue 2 copies of prescription to patients
A new bill will be tabled to secure the patients’ right to know about medicines by obligating issuance of prescriptions for patients to keep.
People’s Party Rep. Do-Ja Choi representatively tabled the ‘Partial Revisi...
Other countries select ‘incentives’ over ‘obligation’ to promote inexpensive drugs
Other countries are reportedly taking various policies for the use of inexpensive drugs, such as nonproprietary names and incentives for generic substitutions.
These policies are carried out with various methods in d...
Start of ‘Warring States’ in hepatitis C market
The hepatitis C treatment market has met the ‘Warring States’ period.
The Ministry of Food and Drug Safety(MFDS) has approved ‘Mavyret,’ an AbbVie Korea’s hepatitis C therapy, on 12 January.
‘Mavyret’ was approved a...
625 medicines bioequivalently tested last year, significantly decreased by 46% from year before
The number of products bioequivalently tested last year was 625 products, decreased by more than 40% compared to the year before.
According to the Ministry of Food and Drug Safety, the entire number of medicines bioe...
Appearance of oral Gaucher disease treatment, ‘Cerdelga’
Sanofi Genzyme has started to enter competition in the Gaucher disease treatment market as launching Cerdelga(generic name: eliglustat), an oral Gaucher disease treatment, with the health insurance benefits.
Sanofi G...
Financial Gain & Expenditure Report make doctors avoid having meals with MRs
The ‘Financial Grain & Expenditure Report’ has brought a huge impact. While it has been obligated to make the report since this January, it has influenced medical representatives(MRs) at pharmaceutical companies.
Acc...
